Latest news
FDA Finalizes Guidance to Broaden Cancer Trial Eligibility Criteria - Clinical Oncology NewsClinical Oncology News · Thu, 06 Aug 2026 16:59:57 GMTCaris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer - PR NewswirePR Newswire · Thu, 06 Aug 2026 12:30:00 GMTEcog and Deepdrive win German Innovation Prize 2024 - Munich StartupMunich Startup · Thu, 30 Jul 2026 07:00:00 GMT